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A sphingolipid inhibitor induces a cytokinesis arrest and blocks
stage differentiation in Giardia lamblia
Abstract
Sphingolipid biosynthesis pathways have recently emerged as a promising target for therapeutic
intervention against pathogens, including parasites. A key step in the synthesis of complex sphingolipids
is the glucosylation of ceramide, mediated by glucosylceramide (GlcCer) synthase, whose activity can
be inhibited by PPMP (1-phenyl-2-palmitoylamino-3-morpholino-1-propanol). In this study, we
investigated whether PPMP inhibits the proliferation and differentiation of the pathogenic parasite
Giardia lamblia, the major cause of parasiteinduced diarrhea worldwide. PPMP was found to block in
vitro parasite replication in a dose-dependent manner, with a 50% inhibitory concentration of 3.5 M.
The inhibition of parasite replication was irreversible at 10 MPPMP, a concentration that did not affect
mammalian cell metabolism. Importantly, PPMP inhibited the completion of cell division at a specific
stage in late cytokinesis. Microscopic analysis of cells incubated with PPMP revealed the aberrant
accumulation of cellular membranes belonging to the endoplasmic reticulum network in the caudal area
of the parasites. Finally, PPMP induced a 90% reduction in G. lamblia differentiation into cysts, the
parasite stage responsible for the transmission of the disease. These results show that PPMP is a
powerful inhibitor of G. lamblia in vitro and that as-yet-uncharacterized sphingolipid biosynthetic
pathways are potential targets for the development of anti-G. lamblia agents.
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Sphingolipid biosynthesis pathways have recently emerged as a promising target for therapeutic intervention
against pathogens, including parasites. A key step in the synthesis of complex sphingolipids is the glucosylation
of ceramide, mediated by glucosylceramide (GlcCer) synthase, whose activity can be inhibited by PPMP
(1-phenyl-2-palmitoylamino-3-morpholino-1-propanol). In this study, we investigated whether PPMP inhibits
the proliferation and differentiation of the pathogenic parasite Giardia lamblia, the major cause of parasite-
induced diarrhea worldwide. PPMP was found to block in vitro parasite replication in a dose-dependent
manner, with a 50% inhibitory concentration of 3.5 M. The inhibition of parasite replication was irreversible
at 10 MPPMP, a concentration that did not affect mammalian cell metabolism. Importantly, PPMP inhibited
the completion of cell division at a specific stage in late cytokinesis. Microscopic analysis of cells incubated with
PPMP revealed the aberrant accumulation of cellular membranes belonging to the endoplasmic reticulum
network in the caudal area of the parasites. Finally, PPMP induced a 90% reduction in G. lamblia differenti-
ation into cysts, the parasite stage responsible for the transmission of the disease. These results show that
PPMP is a powerful inhibitor of G. lamblia in vitro and that as-yet-uncharacterized sphingolipid biosynthetic
pathways are potential targets for the development of anti-G. lamblia agents.
Giardia lamblia is one of the most common parasites found
in the intestinal tracts of vertebrates, including humans (21),
and is the causative agent of giardiasis, an acute or chronic
infection of the intestine. The binucleated parasite is found
worldwide, but the incidence of giardiasis in humans is highest
in developing countries, where the disease is a significant cause
of morbidity, especially in children (11). In addition, giardiasis
is regarded as one of the most common causes of traveler’s
diarrhea (7, 25, 38, 40).
The simple life cycle of G. lamblia consists of replicating
trophozoites, responsible for pathogenesis, and nonreplicating,
environmentally resistant cysts, responsible for disease trans-
mission (35). Currently available anti-G. lamblia drugs target
primarily the trophozoite stage of the parasite. Examples are
metronidazole, the current drug of choice, and nitrofuran com-
pounds such as furazolidone and albendazole. All of these
drugs cause serious in vivo side effects, often in the gastroin-
testinal tract, which frequently necessitate treatment interrup-
tion (9). In vitro genotoxic and cytotoxic effects of nitroimid-
azoles have been shown as well (20, 29). Moreover, the
development of resistance has been demonstrated both in vitro
and in vivo (for comprehensive reviews, see references 3 and
36). Thus, there is a need for safe and improved drugs to treat
giardiasis.
Sphingolipids are essential membrane components of virtu-
ally all eukaryotic cells. An important step in the sphingolipid
biosynthesis pathways is the glucosylation of ceramide medi-
ated by glucosylceramide (GlcCer) synthase, whose activity can
be modulated by pharmacological inhibitors, including PPMP
(DL-threo-1-phenyl-2-palmitoylamino-3-morpholino-1-pro-
panol) (1, 37). In the present study, we examined the sphingo-
lipid biosynthetic pathways as a potential target for anti-G.
lamblia drugs. Previous studies of G. lamblia lipid metabolism
revealed that the parasite has only a limited capability for de
novo lipid synthesis but that it is capable of taking up lipids
from the environment (6), including gangliosides (26) and cer-
amide (13). However, data about G. lamblia lipid requirements
and lipid biosynthesis pathways are still scarce.
Here, we investigated whether G. lamblia is inhibited by the
GlcCer synthase inhibitor PPMP. To evaluate the effects of
PPMP on both trophozoites and encysting G. lamblia cells, we
analyzed essential processes of parasite replication, the integ-
rity of intracellular structures, adhesion, and cyst formation.
MATERIALS AND METHODS
Biochemical reagents. Unless otherwise stated, all chemicals were purchased
from Sigma and cell culture reagents were from GIBCO BRL. PPMP stock
solutions were prepared at 10 mM in methanol. PPMP was freshly diluted to the
concentrations required for the individual experiments.
Parasite and tissue culture. Trophozoites of the G. lamblia strain WBC6
(ATCC catalog number 50803) were grown axenically in 11-ml culture tubes
(Nunc, Roskilde, Denmark) containing Diamond’s TYI-S-33 medium (6a) sup-
plemented with 10% adult bovine serum and bovine bile. Parasites were har-
vested by chilling the culture tubes on ice for 30 min to detach adherent cells, and
cells were collected by centrifugation at 1,000  g for 10 min. Cells were then
resuspended in phosphate-buffered saline (PBS) and counted using the improved
Neubauer chamber. New subcultures were obtained by inoculating 5  104
trophozoites from confluent cultures into new tubes.
Two-step encystation was induced as described previously (10, 12), by culti-
vating the cells for 44 h in medium without bile (preencysting medium) and
subsequently in medium with a higher pH and porcine bile (encysting medium).
Mammalian cells used in this study were Caco-2 (human colon adenocarci-
noma; ATCC HTB 37), intestine 407 (human embryonic jejunoileum; ATCC
CCL-6), and MDBK (Madin-Darby bovine kidney; ATCC CCL-22) cells. Cells
were routinely cultured in Dulbecco’s modified Eagle medium supplemented
with 10% fetal calf serum, 2 mM glutamine, 50 U of penicillin/ml, and 50 g of
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streptomycin/ml at 37°C with 5% CO2 in tissue culture flasks. Cultures were
trypsinized at least once a week.
Drug incubation, adhesion, and reversibility assays. The incubation of tro-
phozoites with PPMP was performed with freshly inoculated subcultures. Para-
sites were allowed to adhere for 8 h and then incubated for an additional 16 h
with PPMP at the concentrations indicated in the figures corresponding to the
individual experiments. The incubation of encysting cells with the drug was
performed in two steps: 7 h of incubation with PPMP in preencysting medium
and an additional 16 h of incubation in encysting medium. Cells were then
harvested and counted as described above.
The adhesion assay was performed by enumerating nonadherent and adherent
parasites from the same culture tube. Nonadherent trophozoites floating in the
culture medium were transferred into a new tube, the tube was chilled on ice to
prevent adhesion to the tube wall, and the trophozoites were collected by cen-
trifugation. The remaining adherent trophozoites in the original culture tube
were harvested as previously described.
The reversibility assay was performed with exponentially growing and station-
ary-phase trophozoites. In the first case, freshly inoculated subcultures were
incubated with the inhibitor for 16 h as described above, harvested, and washed
to remove the drug. Collected parasites were then counted and reinoculated in
the absence of the inhibitor for an additional 24 h, followed by counting. In the
second case, confluent cultures were incubated with the inhibitor for 16 h,
harvested, and washed in PBS and 5  104 trophozoites were used for new
subcultures in the absence of the inhibitor. After an additional 24 h of incuba-
tion, cells were collected and counted as described above.
Nile red staining. Nile red stock solution was prepared at a concentration of
0.5 mg/ml in acetone. Trophozoites were fixed onto glass slides with 3% form-
aldehyde solution in PBS for 45 min, blocked with a solution of 2% bovine serum
albumin and 100 mM glycine in PBS for 1 h, and stained with Nile red at a
concentration of 0.5 g/ml in PBS for 20 min. Cells were extensively washed in
PBS and mounted in VECTASHIELD antifade agent (Vector Laboratories,
Inc., Burlingame, CA) containing 4,6-diamidino-2-phenylindole (DAPI) for nu-
clear staining. Lipid fluorescence was analyzed by employing a filter set for
rhodamine (530- to 560-nm-wavelength band-pass excitation).
Immunofluorescence analysis. Trophozoites and encysting cells were har-
vested as described above, washed twice in ice-cold PBS, and fixed as before onto
glass slides. Fixed cells were permeabilized with 0.2% Triton X-100 in PBS for 20
min, blocked, and incubated with primary antibodies for 1 h. The primary
antibodies used in this study were anti-protein disulfide isomerase 2 (anti-PDI2)
mouse antiserum at a 1:1,000 dilution, anti-IscS rabbit antiserum (a kind gift of
J. Tovar) at a 1:500 dilution, anti-Flex mouse antiserum (corresponding to
Giardia Genome Database open reading frame 8855) at a 1:1,000 dilution, and
Cy3-conjugated anti-cyst wall protein 1 (anti-CWP1) mouse monoclonal anti-
body (Waterborne, New Orleans, LA) at a 1:60 dilution. Fluorophore-conju-
gated secondary antibodies were purchased from Invitrogen (Basel, Switzerland)
and used at a 1:200 dilution. Immunofluorescence analysis was performed on an
SP2 acousto-optical beam splitter confocal laser-scanning microscope (Leica
Microsystems, Wetzlar, Germany) using the appropriate settings. Image stacks of
optical sections were further processed using the Huygens deconvolution soft-
ware package, version 2.7 (Scientific Volume Imaging, Hilversum, The Nether-
lands). Three-dimensional reconstruction and surface rendering were done with
the Imaris software suite (Bitplane, Zurich, Switzerland) using the surpass func-
tions.
Flow cytometric analysis. Fresh G. lamblia subcultures were treated with
PPMP as described above, harvested, and washed in PBS. Parasites (2  106)
were then stained for 30 min at 4°C with propidium iodide (10 g/ml) in PBS
containing 1% Triton X-100. After washing in PBS, cells were incubated for 30
min at 37°C with DNase-free RNase (10 g/ml; Roche, Mannheim, Germany)
and analyzed for DNA content on a FACSCalibur flow cytometer (Becton
Dickinson, Basel, Switzerland).
Mammalian cell metabolic assay. The metabolic activity of mammalian cells
was tested by using the Alamar blue assay. Briefly, Caco-2, CCL-6, and CCL-22
cells were grown to confluence in 96-well plates, incubated for 24 h with PPMP
at the concentrations indicated in the figures, and processed according to the
instructions of the assay manufacturer (Biosource, Camarillo, CA).
RESULTS
PPMP inhibits G. lamblia trophozoite replication. In order
to characterize the effect of the sphingolipid inhibitor PPMP
on G. lamblia, we treated parasite subcultures with different
concentrations of the drug, as described in Materials and
Methods. Control cells grown for 24 h in the absence of the
drug completed an average of three replication cycles (with an
average replication time of 8 h). In contrast, the addition of
PPMP to the culture medium severely inhibited parasite rep-
lication in a dose-dependent manner, with 3.5 M being the
50% inhibitory concentration (IC50) and with 10 M PPMP
arresting parasite replication (Fig. 1A). Incubation with 20 M
PPMP caused parasite lysis and was therefore not included in
the subsequent analyses.
A qualitative assessment by microscopy analysis of cultures
incubated with 10 M PPMP provided a first indication that
the drug compromised cell division, resulting in the accumu-
lation of incompletely divided cells (doublets) containing two
sets of properly segregated nuclear pairs and two ventral disks
(Fig. 1B, inset).
A quantitative analysis revealed that 35% of PPMP-treated
parasites were single cells, whereas 40% were doublets and
25% formed clusters of three connected cells (triplets) (Fig.
1B). In contrast, 85% of untreated parasites were single cells,
only 10% were doublets, and 5% formed triplets. These data
indicate that PPMP interferes with the completion of cell di-
vision, specifically the separation of daughter cells.
Microscopy analysis revealed that doublet cells resulting
FIG. 1. PPMP inhibits the replication of G. lamblia trophozoites.
(A) Freshly inoculated cultures containing equal numbers of tropho-
zoites (day 1) were allowed to adhere for 8 h and subsequently treated
with the indicated concentrations of PPMP or solvent (control [cntl])
for 16 h. Parasites were then harvested and counted (day 2). Results of
a representative experiment are presented as averages of total parasite
numbers  standard errors (n  4). (B) Parasite cultures were treated
with 10 M PPMP or solvent (cntl) as described above, and parasites
in the form of single cells, doublets, and triplets were counted. Results
are presented as percentages of total parasite numbers  standard
errors (n  6). (Inset) Differential interference contrast image of two
incompletely divided parasites (doublet). Asterisks, ventral disks. Scale
bar, 5 m.
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from PPMP incubation had completed karyokinesis. To con-
firm this observation, we performed a population-wide analysis
of DNA content by flow cytometry. The DNA distributions in
untreated trophozoites showed one major peak corresponding
to interphase cells (with eight sets of DNA [8N]) (Fig. 2A).
However, DNA distributions in PPMP-treated cells presented
additional peaks (16N and 24N) mirroring the doublets and
triplets observed by microscopic analysis (Fig. 2B). The DNA
contents of untreated encysting trophozoites (8N) and cysts
(16N) are shown for comparison (Fig. 2C).
PPMP induces the accumulation of G. lamblia intracellular
membranes. To further characterize the PPMP-induced block
of cell division, we examined the patterns of cellular mem-
branes and the endoplasmic reticula (ER) in PPMP-treated
cells by fluorescence microscopy. Membrane staining with the
lipid probe Nile red showed an accumulation of membranes at
the caudal area of the parasites, both in single (Fig. 3A) and in
incompletely divided (Fig. 3B) cells. Labeling with an antibody
against PDI2, a membrane-anchored ER protein, showed that
the accumulated membranes belonged to the ER network
(Fig. 3C).
Next, we analyzed whether PPMP incubation affected the
distribution of mitosomes (mitochondrial remnant organelles)
or flagella in G. lamblia by using anti-IscS antibodies for mi-
tosome labeling, Nile red for flagellar membrane labeling, and
anti-Flex antibodies for the detection of flagellar exit sites. The
typical distribution of mitosomes (27) was not altered in the
presence of PPMP, and the central mitosome complex was
properly duplicated and segregated also in incompletely di-
vided cells (data not shown). Similarly, the number of flagella
and the positions of flagellar exit sites in PPMP-treated cells
were unchanged (data not shown). These results indicate that
the PPMP-induced arrest in cell division occurs at a late stage
of cytokinesis, after organelle segregation into daughter cells.
PPMP inhibits G. lamblia trophozoite adhesion. The ability
of trophozoites to attach to a wide variety of surfaces, including
intestinal epithelia, by means of their ventral disks is essential
for the colonization of the host intestine and is regarded as an
indicator of parasite virulence. To analyze the effect of PPMP
on parasite adhesion, we counted adherent and nonadherent
cells in cultures incubated with 10 M PPMP. In the presence
of the drug, only 50% of the parasites were attached to the
culture tubes, in contrast to control cultures, in which 90% of
the parasites were attached (data not shown). Thus, these data
show that PPMP also compromises the adhesion ability of the
parasites.
FIG. 2. DNA content distributions in PPMP-treated G. lamblia
cells. Freshly inoculated cultures of trophozoites were treated with
solvent (control [cntl]) or 10 M PPMP, as described in Materials and
Methods, or allowed to encyst for 24 h. Parasites were then harvested,
and nuclear DNA was stained with propidium iodide and analyzed by
flow cytometry. T, trophozoites; C, cysts.
FIG. 3. Effect of PPMP on intracellular membranes. Fluorescence
analysis of trophozoites treated with 10 M PPMP or solvent (control
[cntl]) for 16 h. (A and B) Membrane staining with the fluorescent lipid
probe Nile red. (C) ER staining with anti-PDI2 serum followed by
fluorescein-conjugated secondary antibodies. (Insets) Differential in-
terference contrast images. Scale bars, 3 m.
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The PPMP-induced blocking of parasite replication is irre-
versible. We next tested whether the effect of PPMP could be
reversed after the removal of the drug. Both exponentially
replicating and nonreplicating stationary-phase G. lamblia cul-
tures were incubated for 16 h with PPMP and then for 24 h in
the absence of the drug. Parasite replication was assessed by
counting the cells after the incubation in the presence of PPMP
(day 1) and after the subsequent incubation in the absence of
PPMP (day 2). The addition of PPMP to exponentially repli-
cating parasites reduced the division rate (day 1), as demon-
strated previously. During the incubation in the absence of the
drug (day 2), parasites which had been exposed to 5 M PPMP
partially recovered their replication ability, showing a 4.9-fold
increase in cell number during day 2 versus a 5.8-fold increase
in the number of control cells. However, parasites exposed to
10 M PPMP did not replicate after 24 h of incubation in the
absence of the drug (Fig. 4A). In all samples incubated with
PPMP, high percentages of incompletely divided cells and cell
clusters were observed after drug removal (data not shown).
Microscopic examination of the cultures showed no indica-
tion that 10 M PPMP leads directly to cell lysis. This finding
suggests that the cytokinesis defect is the main reason for the
reduced replication rate. Indeed, when PPMP was added to
confluent cultures in stationary phase, cell numbers did not
decrease (data not shown). However, when aliquots of these
drug-treated parasites were used to start new subcultures in the
absence of PPMP, the replication of only those trophozoites
previously exposed to 5 M PPMP was partially restored but
the replication of parasites exposed to 10 M PPMP was com-
pletely inhibited (Fig. 4B). Collectively, these results show that
the inhibition of parasite replication by PPMP at a 10 M
concentration is irreversible and that inhibition by PPMP only
at lower concentrations can be partially reversed. In addition,
the incubation of confluent cells with 10 M PPMP showed
that the irreversible blocking of replication is independent of
active cell division.
PPMP inhibits G. lamblia encystation. Encystation is an
essential process for the transmission of G. lamblia to a new
host and allows parasite survival in the environment. A hall-
mark of encystation is the expression of cyst wall proteins,
which are partitioned into encystation-specific vesicles, from
which they are secreted to form the protective cyst wall.
Given the importance of encystation, we tested whether
PPMP could affect this process. As that of trophozoites, the
treatment of encysting parasites with PPMP caused dose-de-
pendent inhibition of replication compared with the replica-
tion of control cells (Fig. 5A). In addition, we analyzed the
expression of CWP1 and the production of cysts in the pres-
ence of PPMP by immunofluorescence (Fig. 5B). Incubation
with the drug inhibited CWP1 expression in a dose-dependent
manner, with a 10 M concentration reducing the number of
CWP1-positive cells by 80%. The formation of mature cysts
was also inhibited by PPMP, with a 10 M concentration
reducing the number of cysts in the sample by 90%.
These results indicate that PPMP inhibits the replication of
encysting parasites, as well as CWP1 expression and cyst for-
mation.
PPMP effect on mammalian cells. In host organisms, Giar-
dia parasites grow in close contact with intestinal epithelial
cells, to which they attach with a specialized organelle, the
ventral disk. PPMP has been used in vivo in a mouse model at
concentrations inhibitory for G. lamblia in vitro, and the drug
was reported to be well tolerated by the animals (39). How-
ever, PPMP has been shown in vitro to induce apoptosis of a
variety of eukaryotic cells, likely via ceramide buildup (4, 18).
To analyze whether PPMP was detrimental to the mammalian
host cells at concentrations inhibitory for G. lamblia, we tested
the metabolic activity (as a measure of cell viability) of differ-
ent intestinal and kidney cell lines exposed to the drug. As
shown in Fig. 6, cell metabolic activity was unaffected by 24 h
of treatment with a PPMP concentration causing G. lamblia
lysis (20 M). In addition, the IC50 for the three cell lines
tested was above 55 M, more than 10-fold higher than the
IC50 for the parasite (3.5 M). PPMP treatment of host cells
was performed for up to 3 days: while 50 M PPMP induced
apoptotic nuclear condensation events in the treated cells,
neither decreases in metabolic activity and cell number nor an
apoptotic phenotype was observed among cells treated with
PPMP concentrations inhibitory for the parasite (data not
shown). These results show that PPMP at concentrations in-
FIG. 4. Reversibility of PPMP-mediated inhibition of G. lamblia
replication. (A) PPMP treatment during parasite exponential growth.
Freshly inoculated cultures of trophozoites were treated with the in-
dicated PPMP concentrations or solvent (control [cntl]) for 16 h.
Parasites were harvested, counted (day 1), and reinoculated for an
additional 24-h incubation in the absence of the drug before counting
(day 2). (B) PPMP treatment during parasite stationary phase. Con-
fluent cultures of trophozoites were treated with the indicated PPMP
concentrations or solvent (cntl) for 24 h, harvested, and counted.
Aliquots with equal numbers of parasites (day 1) were inoculated into
new cultures for 24 h of incubation in the absence of PPMP before
counting (day 2). Results of representative experiments are presented
as averages of total parasite numbers  standard errors (n  6).
Numbers above the bars represent the increases (n-fold) in parasite
numbers.
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hibitory for G. lamblia does not reduce the viability of mam-
malian cells.
DISCUSSION
Sphingolipid biosynthesis is revealing its potential as a
source of drug targets against a variety of pathogenic organ-
isms, including fungi (28), nematodes (19), and parasites (15–
17, 30, 32). In the present work, we show that PPMP, a known
modulator of sphingolipid biosynthesis, is a strong inhibitor of
the replication and differentiation of cells of the primitive
eukaryote G. lamblia. Most importantly, despite the presence
of the PPMP target in host cells, our data indicate that the
inhibitory effect of the drug on G. lamblia is much greater than
that on the mammalian cells, highlighting the practical feasi-
bility of using sphingolipid inhibitors as a treatment for para-
site infection.
Our data show that micromolar concentrations of PPMP
inhibit three different biological processes of G. lamblia,
namely, parasite replication, adhesion, and differentiation into
cysts. Firstly, the inhibition of replication was dose dependent
and was characterized by a precise arrest in late cytokinesis,
after the nuclei had already successfully duplicated and segre-
gated. Importantly, the irreversibility of the phenotype after
the removal of the drug indicates that structural and/or signal-
ing elements crucial for the proper accomplishment of the cell
cycle were severely compromised. The inhibition of cytokinesis
in yeast and mammalian cells after exposure to sphingolipid
inhibitors with different targets from that of PPMP has been
observed previously (8, 14, 22, 31); however, to our knowledge,
a similar PPMP-mediated impairment of cell division in other
cell systems has not been reported.
Thus, sphingolipids are likely to play an important role in
cell division, although the molecular mechanism is not yet
completely elucidated. A possible explanation for the PPMP-
induced blocking of cytokinesis observed in our study is sug-
gested by the recent investigation of dividing sea urchin eggs
showing that membrane domains enriched with sphingolipids
and cholesterol move to the cleavage furrow separating daugh-
ter cells (24). Interestingly, the isolation of these membrane
domains revealed the presence of signaling molecules, such as
Src and phospholipase C-, whose activation via phosphoryla-
tion is required for furrow progression and actin assembly (24).
Moreover, analyses of the furrow membrane origin showed
highly dynamic membrane trafficking and the fusion of vesicles
derived mainly from the Golgi apparatus (reviewed in refer-
ence 2). Thus, it is tempting to speculate that the addition of
new membrane material, possibly composed of newly synthe-
sized lipids, to the furrow creates signal platforms that help to
orchestrate the cell division process. In this context, the inhi-
bition of lipid synthesis, at a time when lipid demand increases
steeply, may compromise cytokinesis at both the structural and
the signaling levels.
Alternative explanations for the compromised cell division
observed in G. lamblia are alterations at the level of the actin
cytoskeleton, as reported for other cell systems after incuba-
tion with the different sphingolipid inhibitors mentioned above
(8, 22). Although anomalies in actin assembly cannot be ex-
cluded, we did not observe the rounding up of cells, flagellar
FIG. 5. PPMP inhibits G. lamblia encystation. (A) Encysting G.
lamblia cultures were treated with the indicated concentrations of
PPMP or solvent (control [cntl]) as described in Materials and Meth-
ods. Parasites were then harvested and counted. Results of a repre-
sentative experiment are presented as percentages of numbers of un-
treated control parasites  standard errors (n  6). (B) Encysting
parasites were treated with PPMP as described above, harvested, and
stained with anti-CWP1 antibody for immunofluorescence analysis.
The number of parasites expressing CWP1 or forming cysts was nor-
malized by the total number of parasites, assessed by nuclear staining,
and expressed as a percentage of the number of untreated control cells
(cntl)  the standard error (n  6).
FIG. 6. The metabolic activity of host cells treated for 24 h with
solvent (control [cntl]) or PPMP at the indicated concentrations was
assessed by measuring Alamar blue (Biosource) reduction. Results of
a representative experiment are presented as percentages of the activ-
ity of the control cells  standard errors (n  6).
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displacement, or aberrant flagellum numbers, as were reported
following the treatment of G. lamblia with actin inhibitors (5),
suggesting that actin alteration is unlikely to play a major role
in the PPMP-induced inhibition of cell division. In addition,
the observed accumulation of membranes preferentially in the
caudal area of PPMP-treated parasites, where cell division is
blocked, supports a lipid-mediated effect. We are currently
characterizing the target of PPMP in G. lamblia. Two lines of
evidence support GlcCer synthase as a target in this parasite:
(i) a putative gene coding for GlcCer synthase is annotated in
the parasite genome (Giardia Genome Database open reading
frame 11642), and (ii) initial experiments indicate an increase
in ceramide levels in the parasite after PPMP treatment, a
known result of the PPMP-mediated inhibition of GlcCer syn-
thase in mammalian cells (S. Sonda and A. B. Hehl, unpub-
lished data). Hence, our findings suggest that, even with the
high degree of evolutionary divergence between G. lamblia and
higher eukaryotes, key enzymes of sphingolipid biosynthesis
may be highly conserved in this primordial organism.
Secondly, PPMP inhibited not only parasite replication, but
also adhesion. Since attachment is transiently lost during cell
division (34), the most likely explanation for the reduced par-
asite adherence is incomplete cell division and cluster forma-
tion upon PPMP incubation, although direct damage of the
ventral disk responsible for parasite adhesion cannot be ruled
out. The ability to tightly adhere to the intestinal mucosa is
necessary for G. lamblia to colonize the small intestine, and it
is also likely to be responsible for the damage to the intestinal
epithelium, including the disruption of tight junctions, cy-
toskeleton rearrangement, and the apoptosis of host cells (23,
33). Thus, given the role of parasite adherence in the patho-
genesis of the infection, it is tempting to speculate that a
therapeutic compound able to reduce parasite adhesion, like
PPMP, will limit not only the parasite burden, by the prema-
ture excretion of trophozoites, but also the intensity of the
disease symptoms.
Finally, PPMP reduced G. lamblia encystation levels to 10%,
implying that the inhibitor targets a cellular process required
for parasite differentiation. Given the essential role of cyst
formation in both parasite survival in the environment and
transmission to a new host, a pharmacological compound able
to compromise parasite encystation would be extremely valu-
able to contain the spreading of G. lamblia.
In summary, our study demonstrates that PPMP is a potent
anti-G. lamblia drug in vitro. We showed that PPMP acts at
three different levels in the physiology of G. lamblia, leading to
dramatic reductions in parasite replication, adhesion, and en-
cystation. Importantly, these effects occur at concentrations
and incubation times which do not affect the viability of host-
derived cells. PPMP irreversibly inhibits cellular processes that
are essential for both parasite survival in a given host and
parasite transmission to a new host via encystation and excys-
tation. This synergistic effect further adds to the potential of
PPMP as an alternative drug to combat both acute giardiasis
and disease transmission.
ACKNOWLEDGMENTS
We thank Therese Michel for invaluable technical assistance.
This work was supported by grants of the Marie Heim-Vo¨gtlin
Foundation and the Fondation Pierre Mercier pour la Science, Swit-
zerland, to S.S. and grant no. 112327 from the Swiss National Science
Foundation to A.B.H.
REFERENCES
1. Abe, A., J. Inokuchi, M. Jimbo, H. Shimeno, A. Nagamatsu, J. A. Shayman,
G. S. Shukla, and N. S. Radin. 1992. Improved inhibitors of glucosylceramide
synthase. J. Biochem. (Tokyo) 111:191–196.
2. Albertson, R., B. Riggs, and W. Sullivan. 2005. Membrane traffic: a driving
force in cytokinesis. Trends Cell Biol. 15:92–101.
3. Ali, V., and T. Nozaki. 2007. Current therapeutics, their problems, and
sulfur-containing-amino-acid metabolism as a novel target against infections
by “amitochondriate” protozoan parasites. Clin. Microbiol. Rev. 20:164–187.
4. Chan, S. Y., A. L. Hilchie, M. G. Brown, R. Anderson, and D. W. Hoskin.
2007. Apoptosis induced by intracellular ceramide accumulation in MDA-
MB-435 breast carcinoma cells is dependent on the generation of reactive
oxygen species. Exp. Mol. Pathol. 82:1–11.
5. Correa, G., and M. Benchimol. 2006. Giardia lamblia behavior under
cytochalasins treatment. Parasitol. Res. 98:250–256.
6. Das, S., T. Stevens, C. Castillo, A. Villasenor, H. Arredondo, and K. Reddy.
2002. Lipid metabolism in mucous-dwelling amitochondriate protozoa. Int.
J. Parasitol. 32:655–675.
6a.Diamond, L. S., D. R. Harlow, and C. C. Cunnick. 1978. A new medium for
the axenic cultivation of Eutamoeba histolytica and other Entamoeba. Trans.
R. Soc. Trop. Med. Hyg. 72:431–432.
7. Ekdahl, K., and Y. Andersson. 2005. Imported giardiasis: impact of interna-
tional travel, immigration, and adoption. Am. J. Trop. Med. Hyg. 72:825–
830.
8. Endo, M., K. Takesako, I. Kato, and H. Yamaguchi. 1997. Fungicidal action
of aureobasidin A, a cyclic depsipeptide antifungal antibiotic, against Sac-
charomyces cerevisiae. Antimicrob. Agents Chemother. 41:672–676.
9. Gardner, T. B., and D. R. Hill. 2001. Treatment of giardiasis. Clin. Microbiol.
Rev. 14:114–128.
10. Gillin, F. D., S. E. Boucher, S. S. Rossi, and D. S. Reiner. 1989. Giardia
lamblia: the roles of bile, lactic acid, and pH in the completion of the life
cycle in vitro. Exp. Parasitol. 69:164–174.
11. Gilman, R. H., K. H. Brown, G. S. Visvesvara, G. Mondal, B. Greenberg,
R. B. Sack, F. Brandt, and M. U. Khan. 1985. Epidemiology and serology of
Giardia lamblia in a developing country: Bangladesh. Trans. R. Soc. Trop.
Med. Hyg. 79:469–473.
12. Hehl, A. B., M. Marti, and P. Kohler. 2000. Stage-specific expression and
targeting of cyst wall protein-green fluorescent protein chimeras in Giardia.
Mol. Biol. Cell 11:1789–1800.
13. Hernandez, Y., C. Castillo, S. Roychowdhury, A. Hehl, S. B. Aley, and S. Das.
2007. Clathrin-dependent pathways and the cytoskeleton network are in-
volved in ceramide endocytosis by a parasitic protozoan, Giardia lamblia. Int.
J. Parasitol. 37:21–32.
14. Kozutsumi, Y., T. Kanazawa, Y. Sun, T. Yamaji, H. Yamamoto, and H.
Takematsu. 2002. Sphingolipids involved in the induction of multinuclear
cell formation. Biochim. Biophys. Acta 1582:138–143.
15. Labaied, M., A. Dagan, M. Dellinger, M. Geze, S. Egee, S. L. Thomas, C.
Wang, S. Gatt, and P. Grellier. 2004. Anti-Plasmodium activity of ceramide
analogs. Malar. J. 3:49.
16. Lauer, S. A., N. Ghori, and K. Haldar. 1995. Sphingolipid synthesis as a
target for chemotherapy against malaria parasites. Proc. Natl. Acad. Sci.
USA 92:9181–9185.
17. Lauer, S. A., P. K. Rathod, N. Ghori, and K. Haldar. 1997. A membrane
network for nutrient import in red cells infected with the malaria parasite.
Science 276:1122–1125.
18. Litvak, D. A., A. J. Bilchik, and M. C. Cabot. Modulators of ceramide
metabolism sensitize colorectal cancer cells to chemotherapy: a novel treat-
ment strategy. J. Gastrointest. Surg. 7:140–148.
19. Lochnit, G., R. Bongaarts, and R. Geyer. 2005. Searching new targets for
anthelminthic strategies: interference with glycosphingolipid biosynthesis
and phosphorylcholine metabolism affects development of Caenorhabditis
elegans. Int. J. Parasitol. 35:911–923.
20. Lopez Nigro, M. M., A. M. Palermo, M. D. Mudry, and M. A. Carballo. 2003.
Cytogenetic evaluation of two nitroimidazole derivatives. Toxicol. In Vitro
17:35–40.
21. Marshall, M. M., D. Naumovitz, Y. Ortega, and C. R. Sterling. 1997. Water-
borne protozoan pathogens. Clin. Microbiol. Rev. 10:67–85.
22. Meivar-Levy, I., H. Sabanay, A. D. Bershadsky, and A. H. Futerman. 1997.
The role of sphingolipids in the maintenance of fibroblast morphology. The
inhibition of protrusional activity, cell spreading, and cytokinesis induced by
fumonisin B1 can be reversed by ganglioside GM3. J. Biol. Chem. 272:1558–
1564.
23. Muller, N., and N. von Allmen. 2005. Recent insights into the mucosal
reactions associated with Giardia lamblia infections. Int. J. Parasitol. 35:
1339–1347.
24. Ng, M. M., F. Chang, and D. R. Burgess. 2005. Movement of membrane
domains and requirement of membrane signaling molecules for cytokinesis.
Dev. Cell 9:781–790.
568 SONDA ET AL. ANTIMICROB. AGENTS CHEMOTHER.
25. Okhuysen, P. C. 2001. Traveler’s diarrhea due to intestinal protozoa. Clin.
Infect. Dis. 33:110–114.
26. Pope-Delatorre, H., S. Das, and L. N. Irwin. 2005. Uptake of [3H]-ganglio-
sides by an intestinal protozoan, Giardia lamblia. Parasitol. Res. 96:102–106.
27. Regoes, A., D. Zourmpanou, G. Leon-Avila, M. van der Giezen, J. Tovar, and
A. B. Hehl. 2005. Protein import, replication, and inheritance of a vestigial
mitochondrion. J. Biol. Chem. 280:30557–30563.
28. Rittershaus, P. C., T. B. Kechichian, J. C. Allegood, A. H. Merrill, Jr., M.
Hennig, C. Luberto, and M. Del Poeta. 2006. Glucosylceramide synthase is
an essential regulator of pathogenicity of Cryptococcus neoformans. J. Clin.
Investig. 116:1651–1659.
29. Rodriguez Ferreiro, G., L. Cancino Badias, M. Lopez-Nigro, A. Palermo, M.
Mudry, P. Gonzalez Elio, and M. A. Carballo. 2002. DNA single strand
breaks in peripheral blood lymphocytes induced by three nitroimidazole
derivatives. Toxicol. Lett. 132:109–115.
30. Sonda, S., T. Kawahara, K. Katayama, N. Sato, and K. Asano. 2005. Syn-
thesis and pharmacological evaluation of benzamide derivatives as selective
5-HT(4) receptor agonists. Bioorg. Med. Chem. 13:3295–3308.
31. Sun, Y., R. Taniguchi, D. Tanoue, T. Yamaji, H. Takematsu, K. Mori, T.
Fujita, T. Kawasaki, and Y. Kozutsumi. 2000. Sli2 (Ypk1), a homologue of
mammalian protein kinase SGK, is a downstream kinase in the sphingolipid-
mediated signaling pathway of yeast. Mol. Cell. Biol. 20:4411–4419.
32. Sutterwala, S. S., C. H. Creswell, S. Sanyal, A. K. Menon, and J. D. Bangs.
2007. De novo sphingolipid synthesis is essential for viability, but not for
transport of glycosylphosphatidylinositol-anchored proteins, in African try-
panosomes. Eukaryot. Cell 6:454–464.
33. Troeger, H., H. J. Epple, T. Schneider, U. Wahnschaffe, R. Ullrich, G. D.
Burchard, T. Jelinek, M. Zeitz, M. Fromm, and J. D. Schulzke. 2007. Effect
of chronic Giardia lamblia infection on epithelial transport and barrier
function in human duodenum. Gut 56:328–335.
34. Tumova, P., J. Kulda, and E. Nohynkova. 2007. Cell division of Giardia
intestinalis: assembly and disassembly of the adhesive disc, and the cytoki-
nesis. Cell Motil. Cytoskeleton 64:288–298.
35. Upcroft, J., and P. Upcroft. 1998. My favorite cell: Giardia. Bioessays 20:
256–263.
36. Upcroft, P., and J. A. Upcroft. 2001. Drug targets and mechanisms of resis-
tance in the anaerobic protozoa. Clin. Microbiol. Rev. 14:150–164.
37. Vunnam, R. R., and N. S. Radin. 1980. Analogs of ceramide that inhibit
glucocerebroside synthetase in mouse brain. Chem. Phys. Lipids 26:265–278.
38. Wittner, M., and H. B. Tanowitz. 1992. Intestinal parasites in returned
travelers. Med. Clin. N. Am. 76:1433–1448.
39. Wu, X., Y. Kim, B. C. Sun, J. D. Moore, W. A. Shaw, and B. J. Maurer. 2006.
Liquid chromatography method for quantifying D-threo-1-phenyl-2-palmitoyl-
amino-3-morpholino-1-propanol (D-threo-PPMP) in mouse plasma and
liver. J. Chromatogr. B 837:44–48.
40. Yung, A. P., and T. A. Ruff. 1994. Travel medicine. 2. Upon return. Med. J.
Aust. 160:206–212.
VOL. 52, 2008 INHIBITORY EFFECT OF PPMP ON GIARDIA LAMBLIA 569
